ACADIA Pharmaceuticals (ACAD) shares dropped more than 5% on Wednesday. The stock closed at just under $33. ACAD is now well off its June highs of above $41. The pullback offers a good opportunity to get back into ACAD. Remember that there is a major catalyst coming up later this year, which could provide another boost to ACAD shares.